ClinicalTrials.Veeva

Menu

Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery

A

Assiut University

Status

Unknown

Conditions

Breast Cancer

Treatments

Radiation: radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT04815642
Radiation in breast cancer

Details and patient eligibility

About

This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative breast surgery .

Enrollment

50 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. women aged from 18 and up to 55 years old.
  2. Histologically diagnosed with breast carcinoma (ductal and others )
  3. All patients with conservative breast surgery.
  4. Including all patients with in all stages except those stage IV.
  5. All patients with clear free surgical margin.
  6. patients received hypofractionated radiotherapy with weekly concomitant boost

Exclusion criteria

  1. Evidence of distant metastatic deposites.
  2. patients with mastectomy
  3. patients with prior irradiation to thoracic region.
  4. pregnancy or lactation.

Trial contacts and locations

0

Loading...

Central trial contact

Nada Mohamed shawky, Master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems